India, Oct. 9 -- image credit- shutterstock

Rubicon Research, leading specialty pharmaceutical company focused on innovative product development and differentiated generic formulations, has allotted 1,27,64,691 equity shares to 32 anchor investors, comprising marquee domestic and global anchor and raised Rs 619.09 croreaheadof the company's proposed IPO at the upper end of the price band at Rs 485 per equity share with the face value of Rs 1 per equity share.

Out of the total allocation of 1,27,64,691 equity shares to the anchor investors 49,56,750 equity shares were allocated to 8 domestic mutual funds through a total of 18 schemes.

The anchor book witnessed strong participation from a diversified set of high-quality domestic and glob...